Systemic allergic reaction to galcanezumab (emgality): a case report

Michael J Pico1, Malaka Badri2, Nathan Michalak3

  • 1Department of Rehabilitation Medicine, University of California San Francisco, CA, USA.

Summary

A rare systemic allergic reaction to Galcanezumab (Emgality) occurred in a patient with autoimmune conditions. Prompt medical intervention with steroids and antihistamines resolved the severe symptoms.